$USNA

Jones Paul A. sold $129K of USNA

Jones Paul A. (CHIEF PEOPLE OFFICER) sold 6,813 shares of USANA HEALTH SCIENCES INC (USNA) at $18.95 ($0.13M total) on 2026-05-28.

Original reporting
SEC EDGAR · Jones Paul A.
Published May 29, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:52 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$USNA
Neutral
high confidence
Mentioned
$USNA
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$USNANeutralLow
01

Why it matters

The newest fact is the specific insider sale size, price, and post-transaction holdings; it does not include any operational or financial update for USANA.

02

Market read

Traders may note insider selling as a sentiment datapoint, but there is no fundamental catalyst in the filing text.

03

What to watch

The article provides only the sale details, not context like prior holdings, compensation structure, or whether other insiders sold/bought around the same time.

Relevance 4/10Novelty 3/10Timing: filed 2026-05-29 after the sale dated 2026-05-28

Background

The article is a SEC Form 4 insider transaction disclosure for USANA Health Sciences Inc.

Company-level read

Ticker impact

$USNANeutralHigh confidence
Context

USANA disclosed a Form 4 showing Chief People Officer Paul A. Jones sold 6,813 shares at $18.95 on 2026-05-28.

Expected impact

Low near-term impact; any reaction would be sentiment-driven and typically limited.

Evidence & confidence

The filing is a routine insider transaction with no 10b5-1 plan and no accompanying company guidance, deal, or regulatory action in the text.

Market effects

No sector read-through is provided; this appears company-specific and routine.

None indicated.

None indicated.

Counterpoint

Insider sales can be planned for diversification or tax needs; the absence of a 10b5-1 plan does not necessarily imply negative expectations.

Key entities

  • USANA Health Sciences Inc

    Subject of the Form 4 insider transaction disclosure.

  • Paul A. Jones

    Chief People Officer who sold 6,813 shares in an open-market transaction.

Related articles

$USNAHigh

USANA HEALTH SCIENCES INC (USNA): Results of Operations and Financial Condition

USANA HEALTH SCIENCES INC (USNA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026earningsreleaseex991.htm EX-99.1 Document USANA Health Sciences Reports Second Quarter 2026 Results Company Continues Evolution to a Diversified, Omnichannel Health and Wellness Business SALT LAKE CITY, August 4, 2026 (BUSINESS WIRE)—USANA Health Sciences, Inc. (N